Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #7381
Reference
MSAN(2021)26
Name
Glipizide (Minodiab®) 5mg tablets
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
SUPPLIES
Description
1. Pfizer are out of stock of glipizide (Minodiab®) 5mg tablets until mid-October 2021 due to increased demand following the withdrawal of another glipizide 5mg tablet from the UK market.
2. Prescribers will need to review all affected patients and assess ongoing need for glipizide.
3. If ongoing treatment is required, consideration should be given to prescribing an alternative sulfonylurea or glucose lowering medication.
4. Alternative glucose-lowering medications, including sulfonylureas, remain available.
5. Patients with monogenic diabetes* (MODY) should remain on an equivalent dose of an alternative sulfonylurea.
6. Unlicensed supplies of glipizide 5mg tablets have been sourced and may be considered where the above options are inappropriate.
2. Prescribers will need to review all affected patients and assess ongoing need for glipizide.
3. If ongoing treatment is required, consideration should be given to prescribing an alternative sulfonylurea or glucose lowering medication.
4. Alternative glucose-lowering medications, including sulfonylureas, remain available.
5. Patients with monogenic diabetes* (MODY) should remain on an equivalent dose of an alternative sulfonylurea.
6. Unlicensed supplies of glipizide 5mg tablets have been sourced and may be considered where the above options are inappropriate.
Contact Name
Contact Email
Contact Address
Created
2021-08-06 00:00:00
Click to go back to homepage